Molecular Epidemiology of Influenza A(H1N1)pdm09 Viruses from Pakistan in 2009-2010

被引:15
|
作者
Aamir, Uzma Bashir [1 ]
Badar, Nazish [1 ]
Mehmood, Muhammad Rashid [1 ]
Nisar, Nadia [1 ]
Suleman, Rana Muhammad [1 ]
Shaukat, Shehzad [1 ]
Sharif, Salman [1 ]
Kamran, Jaleel
Zaidi, Syed Sohail Zahoor [1 ]
Kazi, Birjees Mazher
Gubareva, Larisa [2 ]
Xu, Xiyan [2 ]
Garten, Rebecca [2 ]
Klimov, Alexander [2 ]
机构
[1] Natl Inst Hlth, Dept Virol, Publ Hlth Labs Div, Islamabad, Pakistan
[2] Ctr Dis Control, Influenza Div, Atlanta, GA 30333 USA
来源
PLOS ONE | 2012年 / 7卷 / 08期
关键词
SWINE; H1N1; EMERGENCE;
D O I
10.1371/journal.pone.0041866
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: In early 2009, a novel influenza A(H1N1) virus that emerged in Mexico and United States rapidly disseminated worldwide. The spread of this virus caused considerable morbidity with over 18000 recorded deaths. The new virus was found to be a reassortant containing gene segments from human, avian and swine influenza viruses. Methods/Results: The first case of human infection with A(H1N1)pdm09 in Pakistan was detected on 18th June 2009. Since then, 262 laboratory-confirmed cases have been detected during various outbreaks with 29 deaths (as of 31st August 2010). The peak of the epidemic was observed in December with over 51% of total respiratory cases positive for influenza. Representative isolates from Pakistan viruses were sequenced and analyzed antigenically. Sequence analysis of genes coding for surface glycoproteins HA and NA showed high degree of high levels of sequence identity with corresponding genes of regional viruses circulating South East Asia. All tested viruses were sensitive to Oseltamivir in the Neuraminidase Inhibition assays. Conclusions: Influenza A(H1N1) pdm09 viruses from Pakistan form a homogenous group of viruses. Their HA genes belong to clade 7 and show antigenic profile similar to the vaccine strain A/California/07/2009. These isolates do not show any amino acid changes indicative of high pathogenicity and virulence. It is imperative to continue monitoring of these viruses for identification of potential variants of high virulence or drug resistance.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Antibodies to Influenza Virus A/H1N1 Hemagglutinin in Type 1 Diabetes Children Diagnosed Before, During and After the SWEDISH A(H1N1)pdm09 Vaccination Campaign 2009-2010
    Svensson, M.
    Ramelius, A.
    Nilsson, A. -L.
    Delli, A. J.
    Larsson, H. Elding
    Carlsson, A.
    Forsander, G.
    Ivarsson, S. A.
    Ludvigsson, J.
    Kockum, I.
    Marcus, C.
    Samuelsson, U.
    Ortqvist, E.
    Lernmark, A.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2014, 79 (02) : 137 - 148
  • [42] Fatal Influenza A(H1N1)pdm09 Encephalopathy in Immunocompetent Man
    Simon, Marie
    Hernu, Romain
    Cour, Martin
    Casalegno, Jean-Sebastien
    Lina, Bruno
    Argaud, Laurent
    EMERGING INFECTIOUS DISEASES, 2013, 19 (06) : 1005 - 1007
  • [43] Influenza A(H1N1)pdm09 virus in pigs, Togo, 2013
    Ducatez, Mariette F.
    Awoume, Felix
    Webby, Richard J.
    VETERINARY MICROBIOLOGY, 2015, 177 (1-2) : 201 - 205
  • [44] Emergence of influenza A (H1N1) PDM09 in the remote Islands of India - A molecular approach
    Muruganandam, N.
    Bhattacharya, D.
    Chaaithanya, I. K.
    Bhattacharya, H.
    Reesu, R.
    Maile, A.
    Bharathi, G. S. J.
    Sugunan, A. P.
    Vijayachari, P.
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2015, 33 (01) : 143 - 146
  • [45] Delayed emergence of oseltamivir-resistant seasonal influenza A (H1N1) and pandemic influenza A(H1N1) pdm09 viruses in Myanmar
    Dapat, Clyde
    Saito, Reiko
    Kyaw, Yadanar
    Myint, Yi Yi
    Oo, Htun Naing
    Oo, Khin Yi
    Naito, Makoto
    Hasegawa, Go
    Dapat, Isolde C.
    Suzuki, Hiroshi
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2013, 7 (05) : 766 - 771
  • [46] Incidence of Influenza A(H1N1) pdm09 Infection, United Kingdom, 2009-2011
    Sridhar, Saranya
    Begom, Shaima
    Bermingham, Alison
    Hoschler, Katja
    Adamson, Walt
    Carman, William
    Van Kerkhove, Maria D.
    Lalvani, Ajit
    EMERGING INFECTIOUS DISEASES, 2013, 19 (11) : 1866 - 1869
  • [47] Evolution of A(H1N1) pdm09 influenza virus masking by glycosylation
    Ge, Pan
    Ross, Ted M.
    EXPERT REVIEW OF VACCINES, 2021, 20 (05) : 519 - 526
  • [48] Outcomes of infants born to women with influenza A(H1N1)pdm09
    Newsome, Kim
    Alverson, C. J.
    Williams, Jennifer
    McIntyre, Anne F.
    Fine, Anne D.
    Wasserman, Cathy
    Lofy, Kathryn H.
    Acosta, Meileen
    Louie, Janice K.
    Jones-Vessey, Kathleen
    Stanfield, Valoree
    Yeung, Alice
    Rasmussen, Sonja A.
    BIRTH DEFECTS RESEARCH, 2019, 111 (02): : 88 - 95
  • [49] Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe
    Mereckiene, J.
    Cotter, S.
    Weber, J. T.
    Nicoll, A.
    D'Ancona, F.
    Lopalco, P. L.
    Johansen, K.
    Wasley, A. M.
    Jorgensen, P.
    Levy-Bruhl, D.
    Giambi, C.
    Stefanoff, P.
    Dematte, L.
    O'Flanagan, D.
    EUROSURVEILLANCE, 2012, 17 (04) : 18 - 27
  • [50] Genetic and potential antigenic evolution of influenza A(H1N1)pdm09 viruses circulating in Kenya during 2009–2018 influenza seasons
    D. Collins Owuor
    Zaydah R. de Laurent
    Bryan O. Nyawanda
    Gideon O. Emukule
    Rebecca Kondor
    John R. Barnes
    D. James Nokes
    Charles N. Agoti
    Sandra S. Chaves
    Scientific Reports, 13